Tirzepatide
Dual GIP and GLP-1 receptor agonist reference material supplied as a lyophilized powder for in-vitro incretin receptor research.
View Tirzepatide recordGLP-1 receptor agonist reference material supplied as a lyophilized powder for in-vitro incretin signalling research.
| Standard product name | Semaglutide |
|---|---|
| CAS number | Not published on this site |
| Published HPLC purity | 99.53% |
| Category | Incretin Receptor Agonists |
| Available specifications | 10 mg, 20 mg, 30 mg, 40 mg |
| Molecular formula | Not published on this site |
| Sequence | Not published on this site |
| Certificate of analysis | Published for lot MBAO7458 — see the data below |
| Ordering | Inquiry only — no price is published |
GLP-1 receptor agonist reference material supplied as a lyophilized powder for in-vitro incretin signalling research.
Semaglutide is released against a batch certificate of analysis issued by Lens Bio Lab for lot MBAO7458. The determinations below are taken from that certificate. Match the lot number on the document you receive to the lot number shown here.
| Determination | Result reported for this lot |
|---|---|
| Lot number | MBAO7458 |
| Specification tested | 10 mg |
| Appearance | White lyophilized powder — conforms |
| Purity — HPLC, UV-VIS @ 214 nm | 99.53% (specification: Not less than 99.0%) |
| Identity — electrospray ionisation mass spectrometry | ESI-MS — mass confirmed at 4113.6 Da |
| Analysed quantity — quantitative HPLC | 10.23 mg (quantitative HPLC, within 10% of target) |
| Sterility — USP <71> | USP <71> — no growth, conforms |
| Heavy metals — ICP-MS | ICP-MS — not detected, conforms |
| Testing laboratory | Lens Bio Lab |
| Sample received / tested | Sep 21, 2026 / Sep 26, 2026 |
These results belong to the specific lot named above. They are not a stability claim, a shelf-life claim or a claim about any other lot. Read the certificate for the lot you receive before use.
See every published lot and the full method list · Read how quality control is handled
A CAS number is not published for Semaglutide on this site. Our published product record lists identity documentation as available on request from the research desk.
The purity value listed for Semaglutide is 99.53%. This figure is the value published on this product record.
The catalog lists Semaglutide as 10 mg / 20 mg / 30 mg / 40 mg in the Incretin Receptor Agonists category. Confirm current availability with the research desk before planning an order.
A batch certificate of analysis is published for this product. The lot number, appearance, HPLC purity, ESI-MS identity confirmation, analysed quantity, sterility and heavy-metal results shown on this page are taken from that certificate. See the certificate of analysis page for the testing laboratory and the full method list.
This catalog is inquiry-based and does not publish prices. Send Semaglutide, the quantity, and the delivery country to the research desk on WhatsApp (+852 44597169) to receive availability and pricing.
Shipping and handling terms are described on the shipping page. See https://novaplexlabs.com/shipping.html for the published shipping information.
Dual GIP and GLP-1 receptor agonist reference material supplied as a lyophilized powder for in-vitro incretin receptor research.
View Tirzepatide recordTriple GIP, GLP-1 and glucagon receptor agonist reference material supplied as a lyophilized powder for in-vitro receptor research.
View Retatrutide recordDual GLP-1 and glucagon receptor agonist reference material supplied as a lyophilized powder for in-vitro incretin research.
View Mazdutide recordGLP-1 receptor agonist reference material supplied for in-vitro incretin signalling research.
View Liraglutide record